Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis
about
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirusCircular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue.Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectorsAdeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expressionMembrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virionsDifferential activation of innate immune responses by adenovirus and adeno-associated virus vectorsAdeno-associated viruses can induce phosphorylation of eIF2alpha via PKR activation, which can be overcome by helper adenovirus type 5 virus-associated RNAPersistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectorsAdeno-associated Virus as a Mammalian DNA VectorAdeno-associated virus: from defective virus to effective vectorRecombinant adeno-associated viral (rAAV) vectors mediate efficient gene transduction in cultured neonatal and adult microgliaTerminal differentiation of cardiac and skeletal myocytes induces permissivity to AAV transduction by relieving inhibition imposed by DNA damage response proteinsRapid, long-term labeling of cells in the developing and adult rodent visual cortex using double-stranded adeno-associated viral vectors.Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction.Quantitative 3D tracing of gene-delivery viral vectors in human cells and animal tissues.The Rep protein of adeno-associated virus type 2 interacts with single-stranded DNA-binding proteins that enhance viral replication.Role of the adenovirus DNA-binding protein in in vitro adeno-associated virus DNA replication.Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation.Cloning and characterization of adeno-associated virus type 5.AAV's anatomy: roadmap for optimizing vectors for translational successAdeno-associated virus vectors and hematologyLarge-scale molecular characterization of adeno-associated virus vector integration in mouse liver.Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers.Attenuation of monocrotaline-induced pulmonary hypertension by luminal adeno-associated virus serotype 9 gene transfer of prostacyclin synthaseAdeno-associated virus type 2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expressionSelf-complementary AAV5 vector facilitates quicker transgene expression in photoreceptor and retinal pigment epithelial cells of normal mouse.Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypesA role for single-stranded templates in cell-free adeno-associated virus DNA replicationImpaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts.Kinetics of recombinant adeno-associated virus-mediated gene transfer.Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction.Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer.Design and packaging of adeno-associated virus gene targeting vectorsCytoplasmic trafficking of the canine parvovirus capsid and its role in infection and nuclear transport.Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinomaRecruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo.Overexpression of cyclin A inhibits augmentation of recombinant adeno-associated virus transduction by the adenovirus E4orf6 protein.Dynamin is required for recombinant adeno-associated virus type 2 infection.
P2860
Q24515072-742746E0-98A2-4789-9EDD-9B89563B5080Q24523073-1C1694C2-AA66-447C-86B3-E1F85E9E40FEQ24523651-ABF45912-2E52-4893-A27A-8BB898B31BADQ24529153-2C0C7216-2AA7-4244-8BF7-395D6EBB737CQ24529167-87BD3323-D428-48E7-A84A-C781B2DF57DEQ24531466-8913452F-CA0D-4762-8FE2-E44223378442Q24673796-CB5CE1E6-C878-4E0B-B43E-DE4E03DC6360Q24681740-121C5429-49A9-409F-A6B1-297D4F159045Q24683259-DB614FFE-B466-43FE-BA04-BDDA2187E58CQ26782605-F9BFBAC1-A7C5-4E28-A058-18AFB5A87A7AQ27498163-947DFEB0-FCC2-45CF-AC30-2B0416293446Q28386583-5EB7CC18-D00E-45F5-A35D-9252AEE79C1AQ28579249-96FC1270-CF01-4A42-B18F-3F3ED4FD47F3Q30495536-40FECDEF-0DB2-438F-A10D-6E3EAC3E24E7Q30495947-1D636D26-F660-4BB8-9129-152C6DBC5BCFQ30505116-DBA93588-ED0D-4669-84D0-6A8244E16B67Q31032266-061F8C07-7237-48CD-86A1-0BC660A9D7EAQ32157164-AE91932B-0EC5-4705-B0D2-6C558C66BAD4Q33604753-E4C44BBF-DD32-4FFB-94C5-8E8A1D784DE7Q33641228-15284B08-6971-4C93-9323-5732B6F8D613Q33659389-EFD3D6FF-FA3F-467E-8F3E-A02E11B64E86Q33695816-435078AA-DDDA-473E-B3D7-05D455CC2535Q33737640-079F3C28-1BB1-4E75-B05F-2AA69D43C8B7Q33781976-C2CD40DA-601F-4C5F-A631-385B6FB71ED4Q33782809-32AC77BD-52E4-481B-8F48-1D08FA245DD6Q33782838-85E9429F-4D2E-40AE-9236-BE20ED3585A7Q33786039-FD76F697-C6CC-4B3F-9EAC-D62C560B22F0Q33787600-3267925B-B9A6-4457-BA06-42F1016BE983Q33793801-3E2CD8E9-B5EB-4336-BF58-123388D326B6Q33796198-26E12A7B-8147-4388-A905-B88954178E0BQ33796712-BF0AA08D-6383-4D94-83A5-BDD8E9A61DACQ33802149-521F0E45-F36D-49B4-975A-2BE539EDD883Q33802664-E6B11D30-E7F5-4AD2-9F2E-B0997683F946Q33802811-D9580B31-1166-45A1-B5FD-8F31ECCA4418Q33804483-A55B7582-B53B-4896-947D-D249D98B61F1Q33805013-886308E6-7FD1-4CD1-8E91-D4A58331B4E7Q33811260-AA2ACF82-124B-47C5-A95F-C185EBD3F2D4Q33811409-D7E44CA6-C856-443C-89CE-1DB550BC0C3BQ33824969-7C1CE797-CFF1-4E4E-8227-79B78DC1797DQ33825510-22790D8F-0000-4CD6-B117-538E1A10555F
P2860
Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Transduction with recombinant ...... ed by leading-strand synthesis
@ast
Transduction with recombinant ...... ed by leading-strand synthesis
@en
Transduction with recombinant ...... ed by leading-strand synthesis
@nl
type
label
Transduction with recombinant ...... ed by leading-strand synthesis
@ast
Transduction with recombinant ...... ed by leading-strand synthesis
@en
Transduction with recombinant ...... ed by leading-strand synthesis
@nl
prefLabel
Transduction with recombinant ...... ed by leading-strand synthesis
@ast
Transduction with recombinant ...... ed by leading-strand synthesis
@en
Transduction with recombinant ...... ed by leading-strand synthesis
@nl
P2093
P2860
P3181
P1433
P1476
Transduction with recombinant ...... ed by leading-strand synthesis
@en
P2093
P2860
P304
P3181
P407
P577
1996-01-01T00:00:00Z